UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Integrated post-surgical colon cancer care planning at the Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital

Journal of clinical oncology, 2016-03, Vol.34 (7_suppl), p.75-75

2016

Volltextzugriff (PDF)

A phase I study of pazopanib with weekly paclitaxel and carboplatin in advanced solid tumors

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.3021-3021

2019

Volltextzugriff (PDF)

Effect of Chemotherapy-Induced-Peripheral-Neuropathy on Spatial-Temporal Gait Parameters in Cancer Patients Post-Chemotherapy

Archives of physical medicine and rehabilitation, 2015-10, Vol.96 (10), p.e64-e64

2015

Volltextzugriff (PDF)

Nivolumab in patients with DNA mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) metastatic colorectal cancer (mCRC): Long-term survival according to prior line of treatment from CheckMate-142

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.554-554

2018

Volltextzugriff (PDF)

Hospital and patient factors associated with resection of the primary tumor at first presentation of metastatic colorectal cancer in the New Jersey State Cancer Registry

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e14689-e14689

2015

Volltextzugriff (PDF)

Combination of nivolumab (nivo) + ipilimumab (ipi) in the treatment of patients (pts) with deficient DNA mismatch repair (dMMR)/high microsatellite instability (MSI-H) metastatic colorectal cancer (mCRC): CheckMate 142 study

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.3531-3531

2017

Volltextzugriff (PDF)

Nivolumab + ipilimumab combination in patients with DNA mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) metastatic colorectal cancer (mCRC): First report of the full cohort from CheckMate-142

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.553-553

2018

Volltextzugriff (PDF)

Variation in use of palliative resection of primary tumor at first presentation of metastatic colorectal cancer within the New Jersey State Cancer Registry

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e17602-e17602

2014

Volltextzugriff (PDF)

Pembrolizumab (MK-3475) in patients (pts) with extensive-stage small cell lung cancer (SCLC): Preliminary safety and efficacy results from KEYNOTE-028

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.7502-7502

2015

Volltextzugriff (PDF)

Nivolumab ± ipilimumab in treatment (tx) of patients (pts) with metastatic colorectal cancer (mCRC) with and without high microsatellite instability (MSI-H): CheckMate-142 interim results

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.3501-3501

2016

Volltextzugriff (PDF)

Concordance of DNA mismatch repair deficient (dMMR)/microsatellite instability (MSI) assessment by local and central testing in patients with metastatic CRC (mCRC) receiving nivolumab (nivo) in CheckMate 142 study

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.3548-3548

2017

Volltextzugriff (PDF)

A phase 1 study of veliparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in combination with cisplatin and etoposide in extensive-stage small cell lung cancer (SCLC) patients: An Eastern Cooperative Oncology Group study (E2511)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.7523-7523

2014

Volltextzugriff (PDF)

CTEP #8850: A phase I trial of riluzole and sorafenib in patients with advanced solid tumors

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.11086-11086

2015

Volltextzugriff (PDF)

First-in-human dose escalation study of oral ONC201 in advanced solid tumors

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.TPS2623-TPS2623

2015

Volltextzugriff (PDF)

A phase I trial of MK-2206 and hydroxychloroquine(HCQ) in solid tumors, melanoma, renal, and prostate cancer to examine the role of autophagy in tumorigenesis

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS2640-TPS2640

2014

Volltextzugriff (PDF)

Phase 1 study assessing dovitinib (TKI258) on the pharmacokinetics of caffeine, diclofenac, omeprazole, and midazolam in patients with advanced solid tumors

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.2581-2581

2014

Volltextzugriff (PDF)

A first-in-human, phase I safety and pharmacokinetic study of genz-644282, a non-camptothecin topoisomerase I inhibitor, in patients with advanced solid tumors

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.2534-2534

2012

Volltextzugriff (PDF)

Assessment of γH2AX levels in circulating tumor cells in patients treated with veliparib in combination with doxorubicin and cyclophosphamide in metastatic breast cancer

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.2582-2582

2013

Volltextzugriff (PDF)

The efficacy and safety of the capecitabine/temozolomide (CAPTEM) regimen in the treatment of well-differentiated neuroendocrine tumors with liver metastasis after failure of previous therapy: Columbia University Medical Center experience

Journal of clinical oncology, 2013-02, Vol.31 (4_suppl), p.308-308

2013

Volltextzugriff (PDF)

A phase I trial of riluzole and sorafenib in patients with advanced solid tumors and melanoma

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.TPS3112-TPS3112

2012

Volltextzugriff (PDF)

CTEP #8342 autophagy modulation with antiangiogenic therapy: A phase I trial of sunitinib (Su) and hydroxychloroquine (HCQ)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.2553-2553

2013

Volltextzugriff (PDF)

2015-2016 Professional Status Task Force Report on Professional Status

Visual Resources Association Bulletin, 2016-01, Vol.43 (1), p.1

2016

Volltextzugriff (PDF)

Geographic disparities in cancer screening and fatalism among a nationally representative sample of US adults

Journal of epidemiology and community health (1979), 2019-12, Vol.73 (12), p.1128

2019

Volltextzugriff (PDF)

Multistate Outbreak of SARS-CoV-2 Infections, Including Vaccine Breakthrough Infections, Associated with Large Public Gatherings, United States

Emerging infectious diseases, 2022-01, Vol.28 (1), p.35-44

2022

Volltextzugriff (PDF)

Quantifying the Effects of 16p11.2 Copy Number Variants on Brain Structure: A Multisite Genetic-First Study

Biological psychiatry (1969), 2018-08, Vol.84 (4), p.253-264

2018

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(35)
Buchkapitel
(1)

Sprache

Englisch
(36)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Humans
(7)
Adult
(3)
Female
(3)
Life Sciences
(3)
Male
(3)
Psychiatry
(3)
Adolescent
(2)
Age
(2)
Cancer
(2)
Child
(2)
Child Development Disorders, Pervasive - Diagnosis
(2)
Child Development Disorders, Pervasive - Genetics
(2)
Chromosome Deletion
(2)
Coronaviruses
(2)
Covid-19
(2)
Decision Making
(2)
Developmental Disabilities - Diagnosis
(2)
Developmental Disabilities - Genetics
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Integrated post-surgical colon cancer care planning at the Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital

A phase I study of pazopanib with weekly paclitaxel and carboplatin in advanced solid tumors

Effect of Chemotherapy-Induced-Peripheral-Neuropathy on Spatial-Temporal Gait Parameters in Cancer Patients Post-Chemotherapy

Nivolumab in patients with DNA mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) metastatic colorectal cancer (mCRC): Long-term survival according to prior line of treatment from CheckMate-142

Hospital and patient factors associated with resection of the primary tumor at first presentation of metastatic colorectal cancer in the New Jersey State Cancer Registry

Combination of nivolumab (nivo) + ipilimumab (ipi) in the treatment of patients (pts) with deficient DNA mismatch repair (dMMR)/high microsatellite instability (MSI-H) metastatic colorectal cancer (mCRC): CheckMate 142 study

Nivolumab + ipilimumab combination in patients with DNA mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) metastatic colorectal cancer (mCRC): First report of the full cohort from CheckMate-142

Variation in use of palliative resection of primary tumor at first presentation of metastatic colorectal cancer within the New Jersey State Cancer Registry

Pembrolizumab (MK-3475) in patients (pts) with extensive-stage small cell lung cancer (SCLC): Preliminary safety and efficacy results from KEYNOTE-028

Nivolumab ± ipilimumab in treatment (tx) of patients (pts) with metastatic colorectal cancer (mCRC) with and without high microsatellite instability (MSI-H): CheckMate-142 interim results

Concordance of DNA mismatch repair deficient (dMMR)/microsatellite instability (MSI) assessment by local and central testing in patients with metastatic CRC (mCRC) receiving nivolumab (nivo) in CheckMate 142 study

A phase 1 study of veliparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in combination with cisplatin and etoposide in extensive-stage small cell lung cancer (SCLC) patients: An Eastern Cooperative Oncology Group study (E2511)

CTEP #8850: A phase I trial of riluzole and sorafenib in patients with advanced solid tumors

First-in-human dose escalation study of oral ONC201 in advanced solid tumors

A phase I trial of MK-2206 and hydroxychloroquine(HCQ) in solid tumors, melanoma, renal, and prostate cancer to examine the role of autophagy in tumorigenesis

Phase 1 study assessing dovitinib (TKI258) on the pharmacokinetics of caffeine, diclofenac, omeprazole, and midazolam in patients with advanced solid tumors

A first-in-human, phase I safety and pharmacokinetic study of genz-644282, a non-camptothecin topoisomerase I inhibitor, in patients with advanced solid tumors

Assessment of γH2AX levels in circulating tumor cells in patients treated with veliparib in combination with doxorubicin and cyclophosphamide in metastatic breast cancer

The efficacy and safety of the capecitabine/temozolomide (CAPTEM) regimen in the treatment of well-differentiated neuroendocrine tumors with liver metastasis after failure of previous therapy: Columbia University Medical Center experience

A phase I trial of riluzole and sorafenib in patients with advanced solid tumors and melanoma

CTEP #8342 autophagy modulation with antiangiogenic therapy: A phase I trial of sunitinib (Su) and hydroxychloroquine (HCQ)

2015-2016 Professional Status Task Force Report on Professional Status

Geographic disparities in cancer screening and fatalism among a nationally representative sample of US adults

Multistate Outbreak of SARS-CoV-2 Infections, Including Vaccine Breakthrough Infections, Associated with Large Public Gatherings, United States

Quantifying the Effects of 16p11.2 Copy Number Variants on Brain Structure: A Multisite Genetic-First Study

Suchergebnisse filtern